Invention Grant
![Process for the preparation of N-[(3-aminooxetan-3-yl) methyl]-2-(1,1-dioxo-3,5-dihydro-1,4-benzothiazepin-4-yl)-6-methyl-quinazolin-4-amine](/docs/US/2019-04-09/US10253022B2/abs.jpg.600x600.jpg)
- Patent Title: Process for the preparation of N-[(3-aminooxetan-3-yl) methyl]-2-(1,1-dioxo-3,5-dihydro-1,4-benzothiazepin-4-yl)-6-methyl-quinazolin-4-amine
-
Application No.: US15988570Application Date: 2018-05-24
-
Publication No.: US10253022B2Publication Date: 2019-04-09
- Inventor: Junli Chen , Yi Ren , Jin She , Lin Wang , Jianhua Yu , Guocai Zhang
- Applicant: Hoffmann-La Roche Inc.
- Applicant Address: US NJ Little Falls
- Assignee: Hoffmann-La Roche Inc.
- Current Assignee: Hoffmann-La Roche Inc.
- Current Assignee Address: US NJ Little Falls
- Agent Lily J. Ackerman
- Main IPC: C07D417/14
- IPC: C07D417/14 ; C07D305/06 ; C07D305/08
![Process for the preparation of N-[(3-aminooxetan-3-yl) methyl]-2-(1,1-dioxo-3,5-dihydro-1,4-benzothiazepin-4-yl)-6-methyl-quinazolin-4-amine](/abs-image/US/2019/04/09/US10253022B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to a novel process for the preparation of a compound of the formula (I): and pharmaceutically acceptable acid addition salts thereof, which is useful for prophylaxis and treatment of respiratory syncytial virus (RSV) infection in mammal or human being.
Public/Granted literature
Information query
